MENU

Science Advisor

Hirohiro Shimoyama
  • Chairman, Asian Society of Cell Therapy (ACTO)
  • Academic Support Specialist, Institute of Medical Science, The University of Tokyo
  • Professor Emeritus, Institute of Hematology, China Kyowa Medical University, Chinese Academy of Medical Sciences
  • Professor Emeritus, Peking University Oncology Hospital
  • Visiting Professor, Fourth Military Medical University
  • Professor Emeritus, Heilongjiang Provincial Blood Disease Research Institute, China
  • Visiting Professor, Dalian Institute of Nationalities
Akio Urabe
  • Advisor,NTT Medical Center Tokyo
  • Director,Nikkei Inc. Health Center
  • Director,Preventive Medicine Center, Kashiwa Tanaka Hospital
  • Meritorious member ,Japan Society of Hematologists Specialist
  • Honorary Member Honorary member,Japanese BioIron Society
  • Japan Infectious Disease Association Specialist
  • Qualified Physician and Meritorious Member,Japanese Society of Internal Medicine
  • Specialist and Honorary member,Japanese Society of Hematology
Tomomitsu Hotta
  • Honorary President,National Cancer Center Japan
  • Former Chairman,National Cancer Research Center Japan
  • Honorary Member Honorary member,Japanese Bio Iron Society
  • Distinguished Service Member,Japanese Society of Clinical Oncology
  • Honorary Member Honorary member,Japanese Society of Lymphoreticular Tissue Science
  • President,Cancer Research Promotion Foundation
  • Executive Director,Japan Cancer Association
  • ​Director,Princess Takamatsu Cancer Research Fund
  • Health and Medical Strategy Advisor,Health and Medical Strategy Office, Cabinet Secretariat
  • Member,Cancer Control Promotion Council, Ministry of Health, Labor and Welfare
  • Chair,Committee on Unapproved and Off-label Drugs with High Medical Needs, Ministry of Health, Labor and Welfare
  • Vice President,Kanagawa Prefectural Hospital Organization
Keiya Ozawa
  • Principal, Shuto Medical School
  • ​Honorary Professor and Visiting Professor, Jichi Medical University
  • Former Director, University Hospital, Institute of Medical Science, The University of Tokyo
  • Professor, Gene Therapy Development Division, Institute of Medical Science, The University of Tokyo
  • Program Supervisor, Regenerative Medicine Projects, Japan Agency for Medical Research and Development (AMED)
  • ​Honorary Member (Former Councilor), Japanese Society of Internal Medicine
  • Honorary Member (Former Vice President and Chair, International Committee), Japanese Society of Hematology
  • Honorary Member (Former Vice President), Japanese Society of Gene and Cell Therapy
  • Member, New York Academy of Sciences

PAGE TOP